This content is machine translated Benign prostatic hyperplasia (BPH) Sabal and Urtica fixed combination: “Real-world” data convincing In a retrospective study with data from over 70 000 elderly male patients, the effects of the phytotherapeutic PRO 160/120 withthe 5α-reductase inhibitors finasteride and dutasteride, and with theα1-adrenoceptor antagonists…
View Post 3 min This content is machine translated Multiparametric MRI in prostate cancer. A means to increase diagnostic accuracy Can multiparametric MRI be used in triage to avoid unnecessary prostate biopsies in some individuals and more targeted biopsies in others? According to the results of a British study published…
View Post 3 min This content is machine translated Prostate Cancer Statins plus hormone therapy prolong progression-free survival We previously reported on the risk-reducing effect of statins in liver cancer prevention. Now, a retrospective study shows intriguing results in prostate cancer: when cholesterol-lowering drugs are used in parallel…
View Post 4 min This content is machine translated Benign prostatic hyperplasia A herbal preparation compared with finasteride Many herbal preparations are characterized by a gentle effect with few side effects. The opinion is also often expressed that phytotherapy acts rather slowly and weaker compared to synthetic agents.…
View Post 7 min This content is machine translated The prostate is not always to blame Obstructive micturition problems in men – State of the art. The term “benign prostatic syndrome” (BPS) describes micturition symptoms associated with the prostate. The term “benign prostatic hyperplasia” (BPH), formerly frequently used to describe micturition symptoms, describes only a histological…
View Post 2 min This content is machine translated Psychological problems with cancer The impact on patient and family is enormous Cancer diseases repeatedly bring patients and their relatives to their psychological limits. To prevent individuals from harming themselves or their children from developing behavioral problems, it is essential to identify…
View Post 2 min This content is machine translated Immunosuppression in prostate cancer New therapeutic targets are being explored What is certain: The survival prognosis of metastatic castration-resistant prostate cancer (mCRPC) has improved – on average from just over one (before 2000) to almost three years [1]. Nevertheless, current…
View Post 5 min This content is machine translated EMUC Congress 2014 Active surveillance and androgen deprivation in prostate cancer. At the EMUC Congress in Lisbon, two sessions highlighted diagnostic and therapeutic strategies in prostate cancer. One was the benefits and effects of Active Surveillance, and the other was a…
View Post 6 min This content is machine translated Localized prostate carcinoma High survival rates after surgical treatment Surgical treatment of localized prostate cancer is standard in patients with a life expectancy of more than ten years. Surgery is aimed not only at tumor control, but also at…
View Post 7 min This content is machine translated Prostate Cancer Therapy Curative treatment of localized prostate carcinoma Today, 90% of prostate cancers are detected at the localized and thus potentially curable stage. Finding the optimal therapeutic strategy for localized carcinoma is challenging for physicians and patients. Active…
View Post 5 min This content is machine translated Diseases of the prostate What is the potential of phytotherapy? At the 29th Swiss Annual Conference on Phytotherapy in Winterthur, the question was posed as to what possibilities phytotherapeutic approaches offer in the therapy of benign prostate syndrome, prostatitis or…
